Form 4: Perspective Therapeutics Director Increases Stake in Company

Director Robert F. Williamson III increases his holdings in Perspective Therapeutics through recent stock purchases.

Summary

• Robert F. Williamson III, a director of Perspective Therapeutics, Inc. [CATX], has increased his beneficial ownership of the company's common stock.
• On March 28, 2025, Williamson acquired 22,192 shares at a price of $2.27 per share.
• On March 31, 2025, he purchased an additional 38,145 shares at a weighted average price of $2.1438, with individual prices ranging from $2.12 to $2.1697.
• Following these transactions, Williamson directly owns 108,982 shares and indirectly owns 366 shares through the RFW3 Revocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects insider buying, which can be seen as positive, but it's a routine transaction disclosure.

Positives

• The director's increased investment could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may view the director's stock purchases as a positive signal.

Key Dates

Keywords

Perspective Therapeutics, CATX, Robert F. Williamson III, Director, Stock Purchase, Beneficial Ownership, Form 4, SEC Filing